Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Rusty is gonna SH1T

<< Previous

Bullboard Posts

Next >>

Comment by bfwon Jan 11, 2021 9:44pm

206 Views

Post# 32273178

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Rusty is gonna SH1T

Agreed. Mackie is likely selling to key US institutions. $40 million bought deal is a good chunk and there is some big money behind that cheque.

Those buyers are *hopefully* just getting their foot in the door and *hopefully* will continue buying in the open market going forward.

bfw

1998novl wrote:

I disagree Rusty, how do you know who Mackie is selling to? Also, the constant abuse of management here is really annoying me! They just pulled off 2 IND approvals by FDA and beat sales estimates! I would think maybe at some point we give them a pass. I would pay 15-25% dilution all day long in order to get noticed...

I'm with management of this one.